Method for determining attention deficit hyperactivity disorder (ADHD) medication dosage and for monitoring the effects of (ADHD) medication

• US 20050038354A1
• Filed: 05/28/2004
• Published: 02/17/2005
• Est. Priority Date: 05/25/2001
• Status: Abandoned Application

• Current Assignee: David L. Patton, Paige Miller, Richard N. Blazey
• Original Assignee: David L. Patton, Paige Miller, Richard N. Blazey
• Inventors: Patton, David L., Miller, Paige, Blazey, Richard N.
• Application Number:
  US10/856,126
• Publication Number:
  US 20050038354A1
• Time in Patent Office: Days
• US Class Current: 600/549
• CPC Class Codes: A61B 3/113 for determining or recording eye movement
• CPC Class Codes: A61B 5/0002 Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network A61B5/07 takes precedence; transmission systems for measured values G08C; transmission H04B; transmission of digital information H04L; wireless communication networks H04W
• CPC Class Codes: A61B 5/01 Measuring temperature of body parts ; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue clinical contact thermometers G01K13/20
• CPC Class Codes: A61B 5/168 Evaluating attention deficit, hyperactivity
• CPC Class Codes: A61B 5/7257 using Fourier transforms
• CPC Class Codes: A61B 5/726 using Wavelet transforms
• CPC Class Codes: G16H 15/00 ICT specially adapted for medical reports, e.g. generation or transmission thereof

Abstract

A method for determining the appropriate dosage of a medication to treat Attention Deficit Hyperactivity Disorder (ADHD) in an individual who has ADHD comprising: sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether the pre-selected parameter has a value indicative of ADHD; and determining the proper dosage of a medication to treat ADHD based upon the determined value of the pre-selected parameter. At a time subsequent to administering the dosage, it is determined if a previously administered dosage of a medication is effective at removing the effects of ADHD as measured by this pre-selected parameter.

Claims

1-19. -19. Cancelled.

20. A method of diagnosing a disorder comprising:

sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; and

analyzing the sampled peripheral skin temperature data for a pre-selected parameter, to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity.

21. The method of claim 20 wherein said data is processed with a fourier transform algorithm to produce frequency and phase data.

22. The method of claim 20 wherein said data is processed with a wavelet transform algorithm to produce frequency and phase data.

23. An apparatus for diagnosing a disorder comprising:

a device for sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data; and

an analyzer for analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity.

24. The method of claim 23 wherein said data is processed with a fourier transform algorithm to produce frequency and phase data.

25. The method of claim 23 wherein said data is processed with a wavelet transform algorithm to produce frequency and phase data.

26. A method for determining the appropriate dosage of a medication comprising:

measuring the stress of a human subject by sampling the peripheral skin temperature of a human subject during a predetermined time interval when the subject is in an inactive state to provide sampled peripheral skin temperature data;

analyzing the sampled peripheral skin temperature data for a pre-selected parameter to determine whether said pre-selected parameter has a value indicative of a disorder characterized by the symptoms of inattention, hyperactivity, and impulsivity; and

determining the proper dosage of a medication to treat said disorder based upon said determined value of said pre-selected parameter; and

at a time subsequent to administering said dosage, determining if the administered dosage of medication is actually effective at removing the symptoms of said disorder as measured by said pre-selected parameter.